Literature DB >> 17627822

The molecular basis of spinal muscular atrophy (SMA) in South African black patients.

R Labrum1, J Rodda, A Krause.   

Abstract

SMA is an autosomal recessive disorder that results in symmetrical muscle weakness and wasting due to degeneration of the anterior horns of the spinal cord. The gene for SMA, the survival motor neuron (SMN) gene is found on chromosome 5q13, in a region harbouring a 500kb duplication, resulting in two copies (a telomeric and a centromeric) of each of the genes found within the duplication. SMN1 is homozygously deleted in approximately 95% of patients worldwide. Results of the current study show that only 51% (42/92) of South African black SMA patients have homozygous deletions of the SMN1 gene. This frequency is significantly lower than observed in the South African white patient group and in other international populations. The pattern of deletions in the South African black patients is also significantly different. In order to elucidate the molecular basis of SMA in the black population, a dosage assay enabling the detection of SMN1 deletion heterozygotes was independently developed. This assay confirmed SMN1 heterozygosity in at least 70% of black non-deletion SMA patients. However, no second disease-causing mutation or a common chromosomal background for this mutation could be identified in these patients. The frequency of SMA in both the black and white population was also determined using the SMN1 gene dosage assay. Results showed that SMA is more common than previously thought with carrier rates of 1 in 50 and 1 in 23 and a predicted birth incidence of 1 in 3574 and 1 in 1945 in the black population and the white population, respectively. Development and incorporation of the SMN1 dosage assay into the molecular diagnostic service will increase the percentage of cases in which the diagnosis of SMA can be confirmed and allow preclinical and prenatal diagnosis. Further gene characterisation and functional studies would need to be performed in order to further define the molecular basis of SMA in the South African black population.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17627822     DOI: 10.1016/j.nmd.2007.05.005

Source DB:  PubMed          Journal:  Neuromuscul Disord        ISSN: 0960-8966            Impact factor:   4.296


  13 in total

1.  Roles of genetic counselors in South Africa.

Authors:  Jennifer G R Kromberg; Tina-Marié Wessels; Amanda Krause
Journal:  J Genet Couns       Date:  2013-05-31       Impact factor: 2.537

2.  Genetic services and testing in South Africa.

Authors:  Jennifer G R Kromberg; Elaine B Sizer; Arnold L Christianson
Journal:  J Community Genet       Date:  2012-06-19

Review 3.  Using Systems Biology and Mathematical Modeling Approaches in the Discovery of Therapeutic Targets for Spinal Muscular Atrophy.

Authors:  Matthew E R Butchbach
Journal:  Adv Neurobiol       Date:  2018

4.  Clinical and Genetic Study of Algerian Patients with Spinal Muscular Atrophy.

Authors:  Y Sifi; K Sifi; A Boulefkhad; N Abadi; Z Bouderda; R Cheriet; M Magen; J P Bonnefont; A Munnich; C Benlatreche; A Hamri
Journal:  J Neurodegener Dis       Date:  2013-03-24

5.  Establishment of Homozygote Mutant Human Embryonic Stem Cells by Parthenogenesis.

Authors:  Silvina Epsztejn-Litman; Yaara Cohen-Hadad; Shira Aharoni; Gheona Altarescu; Paul Renbaum; Ephrat Levy-Lahad; Oshrat Schonberger; Talia Eldar-Geva; Sharon Zeligson; Rachel Eiges
Journal:  PLoS One       Date:  2015-10-16       Impact factor: 3.240

6.  Differences in SMN1 allele frequencies among ethnic groups within North America.

Authors:  B C Hendrickson; C Donohoe; V R Akmaev; E A Sugarman; P Labrousse; L Boguslavskiy; K Flynn; E M Rohlfs; A Walker; B Allitto; C Sears; T Scholl
Journal:  J Med Genet       Date:  2009-07-21       Impact factor: 6.318

Review 7.  Motor Neuron Diseases in Sub-Saharan Africa: The Need for More Population-Based Studies.

Authors:  Emmanuel Quansah; Thomas K Karikari
Journal:  Biomed Res Int       Date:  2015-08-12       Impact factor: 3.411

8.  SMN1 and SMN2 copy numbers in cell lines derived from patients with spinal muscular atrophy as measured by array digital PCR.

Authors:  Deborah L Stabley; Ashlee W Harris; Jennifer Holbrook; Nicholas J Chubbs; Kevin W Lozo; Thomas O Crawford; Kathryn J Swoboda; Vicky L Funanage; Wenlan Wang; William Mackenzie; Mena Scavina; Katia Sol-Church; Matthew E R Butchbach
Journal:  Mol Genet Genomic Med       Date:  2015-03-21       Impact factor: 2.183

9.  Genetics of low spinal muscular atrophy carrier frequency in sub-Saharan Africa.

Authors:  Modibo Sangaré; Brant Hendrickson; Hammadoun Ali Sango; Kelian Chen; Jonathan Nofziger; Abdelbasset Amara; Amalia Dutra; Alice B Schindler; Aldiouma Guindo; Mahamadou Traoré; George Harmison; Evgenia Pak; Fatoumata N'Go Yaro; Katherine Bricceno; Christopher Grunseich; Guibin Chen; Manfred Boehm; Kristen Zukosky; Nouhoum Bocoum; Katherine G Meilleur; Fatoumata Daou; Koumba Bagayogo; Yaya Ibrahim Coulibaly; Mahamadou Diakité; Michael P Fay; Hee-Suk Lee; Ali Saad; Moez Gribaa; Andrew B Singleton; Youssoufa Maiga; Sungyoung Auh; Guida Landouré; Rick M Fairhurst; Barrington G Burnett; Thomas Scholl; Kenneth H Fischbeck
Journal:  Ann Neurol       Date:  2014-04-02       Impact factor: 10.422

Review 10.  Copy Number Variations in the Survival Motor Neuron Genes: Implications for Spinal Muscular Atrophy and Other Neurodegenerative Diseases.

Authors:  Matthew E R Butchbach
Journal:  Front Mol Biosci       Date:  2016-03-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.